Benjamin C. Smeal - 21 May 2025 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role: Director
Signature: /s/ Matthew J. D'Onofrio, Attorney-in-fact for Benjamin C. Smeal
Issuer symbol: EVOK
Transactions as of: 21 May 2025
Net transactions value: $0
Form type: 4
Filing time: 22 May 2025, 17:00:18 UTC
Previous filing: 22 Oct 2024
Next filing: 17 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Smeal Benjamin C.	Director	C/O EVOKE PHARMA, INC., 420 STEVENS AVENUE, SUITE 230, SOLANA BEACH	/s/ Matthew J. D'Onofrio, Attorney-in-fact for Benjamin C. Smeal	22 May 2025	0001748561

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVOK	Stock Option (Right to Buy)	Award	$0	+1,125	+19%	$0.000000	6,958	21 May 2025	Common Stock	1,125	$3.45	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.